Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Bayer patents prostaglandin E2 receptor EP3 subtype antagonists

June 10, 2021

Yuhan Corp. describes compositions including GDF15 variants

June 10, 2021

New GLP-1 receptor agonists identified at ILDONG Pharmaceutical

June 10, 2021

Yuhan Corp. and Green Cross Corp. present ceramide glucosyltransferase inhibitors

June 9, 2021

New PDE6C and PDE5A inhibitors discovered at ILDONG Pharmaceutical

June 9, 2021

Suzhou Zelgen Biosciences divulges Toll-like receptor 7/8 agonists

June 9, 2021

New mucolipin-1 activators identified at Libra Therapeutics

June 9, 2021

Nippon Shinyaku patents muscarinic acetylcholine M3 receptor positive allosteric modulators

June 9, 2021

New N-acetyl-beta-D-glucosaminidase inhibitors identified at Janssen

June 8, 2021

Sichuan Haisco Pharmaceutical patents G12C mutant KRAS inhibitors

June 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...